Supporting the

Neuroendocrine Cancer Community

NETTER-2 Study Results: Looking Beyond The headlines.

NETTER-2 Study Results: Looking Beyond The headlines.

The latest breakthrough in neuroendocrine cancer treatment comes from the NETTER-2 trial, where Lutetium (177Lu) oxodotreotide, a radio-labeled somatostatin analog, has shown remarkable success in treating high-grade advanced gastroenteropancreatic neuroendocrine...
Unwind Your Mind: Join Our 8-Week Mindfulness Programme

Unwind Your Mind: Join Our 8-Week Mindfulness Programme

– Mindfulness for Managing Pain, Anxiety and Fatigue  In March 2023, our counselling and psychotherapy partners at RareMinds ran an Online (Zoom) taster session on ‘Mindfulness for Pain and Fatigue’ for our Neuroendocrine Cancer community. Following on from the...
Exciting News: Webi-Natter Returns in 2024!

Exciting News: Webi-Natter Returns in 2024!

We’re thrilled to announce the return of our Natter support group meetings for 2024! Join us for the kickoff event, our first Webi-Natter, happening next Monday. – – 📅 Save the Date: – Date: Monday, 15th January 2024 – Time: 6:30 pm...